Clinical Effectiveness of myChoice® CDx Genomic Instability as a CDx Biomarker

Time: 1:00 pm
day: Day One

Details:

– Explore the only FDA approved HRD score CDx to prescribe PARPi’s
– Understand the use of broad biomarker offering for patient selection and therapeutic response
– Germline, somatic (myChoice HRD score, and gene panel), TMB, MSI
– Assessing gold standard myChoice HRD vs. other HRD measures

Speakers: